水肿-话题@MedSci

#水肿#

227篇内容 | 2573人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1333492, encodeId=3caa13334920a, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=临床笔记 | 如何鉴别脑水肿（血管源性、细胞毒性、间质性）？, objectType=article, longId=219262, objectId=98b3219262a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98b3219262a2, replyNumber=0, likeNumber=52, createdTime=2021-10-27, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98b3219262a2, moduleTitle=临床笔记 | 如何鉴别脑水肿（血管源性、细胞毒性、间质性）？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98b3219262a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333491, encodeId=d8b013334914c, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=一文带你看不同类型肺水肿的CT表现！, objectType=article, longId=218954, objectId=3c5c2189543b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c5c2189543b, replyNumber=0, likeNumber=59, createdTime=2021-10-22, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c5c2189543b, moduleTitle=一文带你看不同类型肺水肿的CT表现！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c5c2189543b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333490, encodeId=fcca1333490df, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=诺华宣布FDA接受Beovu治疗糖尿病黄斑水肿患者的申请, objectType=article, longId=218746, objectId=47b2218e46d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47b2218e46d3, replyNumber=0, likeNumber=44, createdTime=2021-10-18, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47b2218e46d3, moduleTitle=诺华宣布FDA接受Beovu治疗糖尿病黄斑水肿患者的申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47b2218e46d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333489, encodeId=0b681333489e7, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=AJKD:乙酰唑胺联合氢氯噻嗪继之使用呋塞米vs呋塞米联合氢氯噻嗪继之使用呋塞米治疗成人肾性水肿的疗效对比, objectType=article, longId=217180, objectId=b5ab21e1805c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5ab21e1805c, replyNumber=0, likeNumber=31, createdTime=2021-09-17, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5ab21e1805c, moduleTitle=AJKD:乙酰唑胺联合氢氯噻嗪继之使用呋塞米vs呋塞米联合氢氯噻嗪继之使用呋塞米治疗成人肾性水肿的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5ab21e1805c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333488, encodeId=4fa91333488ed, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=JACC：缓激肽受体B2基因附近的常见变异可增加ACEi相关血管性水肿风险, objectType=article, longId=215846, objectId=377e2158469e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=377e2158469e, replyNumber=0, likeNumber=30, createdTime=2021-08-18, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=377e2158469e, moduleTitle=JACC：缓激肽受体B2基因附近的常见变异可增加ACEi相关血管性水肿风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=377e2158469e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333487, encodeId=5cb6133348e97, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=Ear Nose Throat J：突发感音神经性听力损失儿童的临床特征与内淋巴水肿的相关性, objectType=article, longId=210648, objectId=e8c2210648f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8c2210648f3, replyNumber=0, likeNumber=37, createdTime=2021-05-01, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8c2210648f3, moduleTitle=Ear Nose Throat J：突发感音神经性听力损失儿童的临床特征与内淋巴水肿的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8c2210648f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333486, encodeId=82ed1333486fa, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=PRS：淋巴水肿怎么治？美国整形外科医生协会发布共识啦！, objectType=article, longId=210297, objectId=d04421029e5b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d04421029e5b, replyNumber=0, likeNumber=45, createdTime=2021-04-23, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d04421029e5b, moduleTitle=PRS：淋巴水肿怎么治？美国整形外科医生协会发布共识啦！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d04421029e5b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333485, encodeId=617e1333485cd, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=PRS：使用吲哚青绿淋巴造影进行逆向淋巴结定位来尽可能减少乳房重建皮瓣供区出现淋巴水肿, objectType=article, longId=210291, objectId=1dd9210291b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1dd9210291b6, replyNumber=0, likeNumber=22, createdTime=2021-04-23, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1dd9210291b6, moduleTitle=PRS：使用吲哚青绿淋巴造影进行逆向淋巴结定位来尽可能减少乳房重建皮瓣供区出现淋巴水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1dd9210291b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333484, encodeId=89e013334849c, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=武田针对急性遗传性血管性水肿发作的治疗药物飞泽优®获批，保障中国HAE患者生命安全, objectType=article, longId=209352, objectId=229a20935293, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=229a20935293, replyNumber=0, likeNumber=31, createdTime=2021-04-04, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=229a20935293, moduleTitle=武田针对急性遗传性血管性水肿发作的治疗药物飞泽优®获批，保障中国HAE患者生命安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=229a20935293)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333483, encodeId=84921333483e9, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=PRS：提高乳腺癌患者生活质量！即刻淋巴重建术有利于预防乳腺癌治疗后的淋巴水肿, objectType=article, longId=208359, objectId=a4c320835951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4c320835951, replyNumber=0, likeNumber=42, createdTime=2021-03-15, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4c320835951, moduleTitle=PRS：提高乳腺癌患者生活质量！即刻淋巴重建术有利于预防乳腺癌治疗后的淋巴水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4c320835951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333482, encodeId=7343133348296, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=浙江有关遗传性血管性水肿调研出炉聚焦罕见病患者困境, objectType=article, longId=208022, objectId=3b102080221a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b102080221a, replyNumber=0, likeNumber=0, createdTime=2021-03-08, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b102080221a, moduleTitle=浙江有关遗传性血管性水肿调研出炉聚焦罕见病患者困境, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b102080221a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333481, encodeId=dfe21333481b8, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=Stroke：中性粒细胞与淋巴细胞比值可预测脑卒中患者再灌注治疗后早期脑水肿和临床恶化, objectType=article, longId=207434, objectId=e00e20e43416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e00e20e43416, replyNumber=0, likeNumber=33, createdTime=2021-02-23, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e00e20e43416, moduleTitle=Stroke：中性粒细胞与淋巴细胞比值可预测脑卒中患者再灌注治疗后早期脑水肿和临床恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e00e20e43416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333480, encodeId=04ac133348047, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=AAAAI 2021：PHA121治疗遗传性血管性水肿（HAE）取得积极结果, objectType=article, longId=207428, objectId=a3c020e428da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3c020e428da, replyNumber=0, likeNumber=44, createdTime=2021-02-23, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c020e428da, moduleTitle=AAAAI 2021：PHA121治疗遗传性血管性水肿（HAE）取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3c020e428da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333479, encodeId=adde13334e977, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色, objectType=article, longId=207129, objectId=d13920e12909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d13920e12909, replyNumber=0, likeNumber=29, createdTime=2021-02-16, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d13920e12909, moduleTitle=长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d13920e12909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333478, encodeId=5b3113334e8c7, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=Sci Rep：膀胱镜下水肿特征提供了间质性膀胱炎治疗后的临床和长期预后特性, objectType=article, longId=206506, objectId=08fb20650632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08fb20650632, replyNumber=0, likeNumber=35, createdTime=2021-02-02, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08fb20650632, moduleTitle=Sci Rep：膀胱镜下水肿特征提供了间质性膀胱炎治疗后的临床和长期预后特性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08fb20650632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333477, encodeId=8b4013334e738, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=日本厚生劳动省（MHLW）批准ORLADEYO（贝罗司他）用于遗传性血管性水肿的预防性治疗, objectType=article, longId=206188, objectId=8ad420618870, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ad420618870, replyNumber=0, likeNumber=34, createdTime=2021-01-26, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ad420618870, moduleTitle=日本厚生劳动省（MHLW）批准ORLADEYO（贝罗司他）用于遗传性血管性水肿的预防性治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ad420618870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333476, encodeId=af9613334e654, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=罗氏的Faricimab在糖尿病性黄斑水肿研究中大获成功, objectType=article, longId=205045, objectId=31af20504527, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31af20504527, replyNumber=0, likeNumber=34, createdTime=2021-01-01, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31af20504527, moduleTitle=罗氏的Faricimab在糖尿病性黄斑水肿研究中大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31af20504527)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333475, encodeId=af0513334e583, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=JNNP:COVID-19疫情封锁对乳头状水肿和特发性颅内高压的影响, objectType=article, longId=204881, objectId=52782048814f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52782048814f, replyNumber=0, likeNumber=40, createdTime=2020-12-27, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52782048814f, moduleTitle=JNNP:COVID-19疫情封锁对乳头状水肿和特发性颅内高压的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52782048814f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333474, encodeId=821013334e456, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=全新糖尿病性黄斑水肿（DME）筛查模型，简单高效助力大规模早筛, objectType=article, longId=204074, objectId=deee2040e43f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deee2040e43f, replyNumber=0, likeNumber=31, createdTime=2020-12-04, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deee2040e43f, moduleTitle=全新糖尿病性黄斑水肿（DME）筛查模型，简单高效助力大规模早筛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deee2040e43f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333473, encodeId=ff5713334e357, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=全球不依赖眼底成像的糖尿病性黄斑水肿预测模型重磅发布，提升DME筛查效率，助力糖尿病综合管理, objectType=article, longId=204068, objectId=b2a120406857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a120406857, replyNumber=0, likeNumber=31, createdTime=2020-12-04, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a120406857, moduleTitle=全球不依赖眼底成像的糖尿病性黄斑水肿预测模型重磅发布，提升DME筛查效率，助力糖尿病综合管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2a120406857)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

水肿

2020-05-29

小华子 (审核中...)

前往app查看评论内容

#水肿#

临床笔记 | 如何鉴别脑水肿（血管源性、细胞毒性、间质性）？

2021-10-27

小华子 (审核中...)

前往app查看评论内容

#水肿#

一文带你看不同类型肺水肿的CT表现！

2021-10-22

小华子 (审核中...)

前往app查看评论内容

#水肿#

诺华宣布FDA接受Beovu治疗糖尿病黄斑水肿患者的申请

2021-10-18

小华子 (审核中...)

前往app查看评论内容

#水肿#

AJKD:乙酰唑胺联合氢氯噻嗪继之使用呋塞米vs呋塞米联合氢氯噻嗪继之使用呋塞米治疗成人肾性水肿的疗效对比

2021-09-17

小华子 (审核中...)

前往app查看评论内容

#水肿#

JACC：缓激肽受体B2基因附近的常见变异可增加ACEi相关血管性水肿风险

2021-08-18

小华子 (审核中...)

前往app查看评论内容

#水肿#

Ear Nose Throat J：突发感音神经性听力损失儿童的临床特征与内淋巴水肿的相关性

2021-05-01

小华子 (审核中...)

前往app查看评论内容

#水肿#

PRS：淋巴水肿怎么治？美国整形外科医生协会发布共识啦！

2021-04-23

小华子 (审核中...)

前往app查看评论内容

#水肿#

PRS：使用吲哚青绿淋巴造影进行逆向淋巴结定位来尽可能减少乳房重建皮瓣供区出现淋巴水肿

2021-04-23

小华子 (审核中...)

前往app查看评论内容

#水肿#

武田针对急性遗传性血管性水肿发作的治疗药物飞泽优®获批，保障中国HAE患者生命安全

2021-04-04

小华子 (审核中...)

前往app查看评论内容

#水肿#

PRS：提高乳腺癌患者生活质量！即刻淋巴重建术有利于预防乳腺癌治疗后的淋巴水肿

2021-03-15

小华子 (审核中...)

前往app查看评论内容

#水肿#

浙江有关遗传性血管性水肿调研出炉聚焦罕见病患者困境

2021-03-08

小华子 (审核中...)

前往app查看评论内容

#水肿#

Stroke：中性粒细胞与淋巴细胞比值可预测脑卒中患者再灌注治疗后早期脑水肿和临床恶化

2021-02-23

小华子 (审核中...)

前往app查看评论内容

#水肿#

AAAAI 2021：PHA121治疗遗传性血管性水肿（HAE）取得积极结果

2021-02-23

小华子 (审核中...)

前往app查看评论内容

#水肿#

长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色

2021-02-16

小华子 (审核中...)

前往app查看评论内容

#水肿#

Sci Rep：膀胱镜下水肿特征提供了间质性膀胱炎治疗后的临床和长期预后特性

2021-02-02

小华子 (审核中...)

前往app查看评论内容

#水肿#

日本厚生劳动省（MHLW）批准ORLADEYO（贝罗司他）用于遗传性血管性水肿的预防性治疗

2021-01-26

小华子 (审核中...)

前往app查看评论内容

#水肿#

罗氏的Faricimab在糖尿病性黄斑水肿研究中大获成功

2021-01-01

小华子 (审核中...)

前往app查看评论内容

#水肿#

JNNP:COVID-19疫情封锁对乳头状水肿和特发性颅内高压的影响

2020-12-27

小华子 (审核中...)

前往app查看评论内容

#水肿#

全新糖尿病性黄斑水肿（DME）筛查模型，简单高效助力大规模早筛

2020-12-04

小华子 (审核中...)

前往app查看评论内容

#水肿#

全球不依赖眼底成像的糖尿病性黄斑水肿预测模型重磅发布，提升DME筛查效率，助力糖尿病综合管理

2020-12-04

科室
- - 订阅+
  - 更多科室
工具
服务